African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination
BK-SE36, based on Plasmodium falciparum serine repeat antigen 5 (SERA5), is a blood-stage malaria vaccine candidate currently being evaluated in clinical trials. Phase 1 trials in Uganda and Burkina Faso have demonstrated promising safety and immunogenicity profiles. However, the genetic diversity o...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 December 2022
|
| In: |
Frontiers in Cellular and Infection Microbiology
Year: 2022, Volume: 12, Pages: 1-15 |
| ISSN: | 2235-2988 |
| DOI: | 10.3389/fcimb.2022.1058081 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fcimb.2022.1058081 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fcimb.2022.1058081 |
| Author Notes: | Nobuko Arisue, Nirianne Marie Q. Palacpac, Edward H. Ntege, Adoke Yeka, Betty Balikagala, Bernard N. Kanoi, Edith Christiane Bougouma, Alfred B. Tiono, Issa Nebie, Amidou Diarra, Sophie Houard, Flavia D’Alessio, Odile Leroy, Sodiomon B. Sirima, Thomas G. Egwang and Toshihiro Horii |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1837172196 | ||
| 003 | DE-627 | ||
| 005 | 20230706232444.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230221s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fcimb.2022.1058081 |2 doi | |
| 035 | |a (DE-627)1837172196 | ||
| 035 | |a (DE-599)KXP1837172196 | ||
| 035 | |a (OCoLC)1389535496 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Arisue, Nobuko |e VerfasserIn |0 (DE-588)1281528919 |0 (DE-627)1837173052 |4 aut | |
| 245 | 1 | 0 | |a African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination |c Nobuko Arisue, Nirianne Marie Q. Palacpac, Edward H. Ntege, Adoke Yeka, Betty Balikagala, Bernard N. Kanoi, Edith Christiane Bougouma, Alfred B. Tiono, Issa Nebie, Amidou Diarra, Sophie Houard, Flavia D’Alessio, Odile Leroy, Sodiomon B. Sirima, Thomas G. Egwang and Toshihiro Horii |
| 264 | 1 | |c 16 December 2022 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.02.2023 | ||
| 520 | |a BK-SE36, based on Plasmodium falciparum serine repeat antigen 5 (SERA5), is a blood-stage malaria vaccine candidate currently being evaluated in clinical trials. Phase 1 trials in Uganda and Burkina Faso have demonstrated promising safety and immunogenicity profiles. However, the genetic diversity of sera5 in Africa and the role of allele/variant-specific immunity remain a major concern. Here, sequence analyses were done on 226 strains collected from the two clinical trial/follow-up studies and 88 strains from two cross-sectional studies in Africa. Compared to other highly polymorphic vaccine candidate antigens, polymorphisms in sera5 were largely confined to the repeat regions of the gene. Results also confirmed a SERA5 consensus sequence with African-specific polymorphisms. | ||
| 700 | 1 | |a Palacpac, Nirianne Marie Q. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ntege, Edward H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yeka, Adoke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Balikagala, Betty |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kanoi, Bernard N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bougouma, Edith Christiane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tiono, Alfred B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nebie, Issa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diarra, Amidou |e VerfasserIn |4 aut | |
| 700 | 1 | |a Houard, Sophie |e VerfasserIn |0 (DE-588)1122674457 |0 (DE-627)876003072 |0 (DE-576)481436057 |4 aut | |
| 700 | 1 | |a D'Alessio, Flavia |e VerfasserIn |0 (DE-588)1030450552 |0 (DE-627)735281912 |0 (DE-576)378268597 |4 aut | |
| 700 | 1 | |a Leroy, Odile |e VerfasserIn |0 (DE-588)1081792701 |0 (DE-627)846672553 |0 (DE-576)45479732X |4 aut | |
| 700 | 1 | |a Sirima, Sodiomon B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Egwang, Thomas G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Horii, Toshihiro |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in Cellular and Infection Microbiology |d Lausanne : Frontiers Media, 2010 |g 12(2022), Artikel-ID 1058081, Seite 1-15 |h Online-Ressource |w (DE-627)664968554 |w (DE-600)2619676-1 |w (DE-576)347917410 |x 2235-2988 |7 nnas |a African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g elocationid:1058081 |g pages:1-15 |g extent:15 |a African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fcimb.2022.1058081 |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fcimb.2022.1058081 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230221 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1081792701 |a Leroy, Odile |m 1081792701:Leroy, Odile |d 910000 |e 910000PL1081792701 |k 0/910000/ |p 13 | ||
| 998 | |g 1030450552 |a D'Alessio, Flavia |m 1030450552:D'Alessio, Flavia |d 910000 |e 910000PD1030450552 |k 0/910000/ |p 12 | ||
| 999 | |a KXP-PPN1837172196 |e 4275171330 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 21.02.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1837172196","language":["eng"],"title":[{"title":"African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination","title_sort":"African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Arisue, Nobuko","given":"Nobuko","family":"Arisue"},{"family":"Palacpac","given":"Nirianne Marie Q.","display":"Palacpac, Nirianne Marie Q.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Ntege","given":"Edward H.","roleDisplay":"VerfasserIn","display":"Ntege, Edward H.","role":"aut"},{"display":"Yeka, Adoke","roleDisplay":"VerfasserIn","role":"aut","family":"Yeka","given":"Adoke"},{"role":"aut","display":"Balikagala, Betty","roleDisplay":"VerfasserIn","given":"Betty","family":"Balikagala"},{"given":"Bernard N.","family":"Kanoi","role":"aut","roleDisplay":"VerfasserIn","display":"Kanoi, Bernard N."},{"given":"Edith Christiane","family":"Bougouma","role":"aut","roleDisplay":"VerfasserIn","display":"Bougouma, Edith Christiane"},{"given":"Alfred B.","family":"Tiono","role":"aut","roleDisplay":"VerfasserIn","display":"Tiono, Alfred B."},{"family":"Nebie","given":"Issa","display":"Nebie, Issa","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Amidou","family":"Diarra","role":"aut","roleDisplay":"VerfasserIn","display":"Diarra, Amidou"},{"family":"Houard","given":"Sophie","display":"Houard, Sophie","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Flavia","family":"D'Alessio","role":"aut","roleDisplay":"VerfasserIn","display":"D'Alessio, Flavia"},{"given":"Odile","family":"Leroy","role":"aut","display":"Leroy, Odile","roleDisplay":"VerfasserIn"},{"family":"Sirima","given":"Sodiomon B.","display":"Sirima, Sodiomon B.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Thomas G.","family":"Egwang","role":"aut","roleDisplay":"VerfasserIn","display":"Egwang, Thomas G."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Horii, Toshihiro","given":"Toshihiro","family":"Horii"}],"physDesc":[{"extent":"15 S."}],"relHost":[{"title":[{"title_sort":"Frontiers in Cellular and Infection Microbiology","title":"Frontiers in Cellular and Infection Microbiology"}],"recId":"664968554","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccinationFrontiers in Cellular and Infection Microbiology","note":["Gesehen am 21.07.11"],"part":{"year":"2022","pages":"1-15","volume":"12","text":"12(2022), Artikel-ID 1058081, Seite 1-15","extent":"15"},"pubHistory":["2010 -"],"id":{"issn":["2235-2988"],"eki":["664968554"],"zdb":["2619676-1"]},"origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2010-","dateIssuedKey":"2010","publisher":"Frontiers Media"}],"physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"16 December 2022","dateIssuedKey":"2022"}],"id":{"doi":["10.3389/fcimb.2022.1058081"],"eki":["1837172196"]},"name":{"displayForm":["Nobuko Arisue, Nirianne Marie Q. Palacpac, Edward H. Ntege, Adoke Yeka, Betty Balikagala, Bernard N. Kanoi, Edith Christiane Bougouma, Alfred B. Tiono, Issa Nebie, Amidou Diarra, Sophie Houard, Flavia D’Alessio, Odile Leroy, Sodiomon B. Sirima, Thomas G. Egwang and Toshihiro Horii"]}} | ||
| SRT | |a ARISUENOBUAFRICANSPE1620 | ||